Carmen Elena Gómez | Vaccine | Innovative Research Award

Innovative Research Award

Carmen Elena Gómez
National Biotechnology Center | CSIC

          Carmen Elena Gómez
Affiliation National Biotechnology Center | CSIC
Country Spain
Scopus ID 35796367700
Documents 291
Citations 10,146
h-index 47
Subject Area Vaccine
Event Global Diseases Research Awards
ORCID 0000-0002-9473-283X

Carmen Elena Gómez is a researcher affiliated with the National Biotechnology Center of the Spanish National Research Council (CSIC), Spain. Her scientific activities focus on vaccine research, biotechnology, and biomedical innovation. The Innovative Research Award recognizes distinguished contributions in developing impactful scientific approaches and advancing research knowledge within the global health landscape. Research profiles and publication records are evaluated through internationally recognized scholarly databases including Scopus.[1]

Abstract

The Innovative Research Award highlights researchers whose scientific achievements contribute to advances in biomedical sciences and healthcare innovation. Carmen Elena Gómez has established a research profile associated with vaccine development and biotechnology, supported by extensive scholarly publications, citation impact, and international scientific recognition. Her work represents contributions toward understanding and improving vaccine technologies for public health applications.[1]

Keywords

Vaccine Research, Biotechnology Innovation, Immunology, Biomedical Research and Scientific Excellence. [2]

Introduction

Vaccines represent a major area of biomedical research aimed at preventing infectious diseases and improving population health outcomes. Researchers working in vaccine science contribute through immunological studies, platform development, translational research, and evaluation of novel strategies. Carmen Elena Gómez’s academic contributions align with these objectives through research activities documented in international scientific databases.[2]

Research Profile

The researcher profile indicates affiliation with the National Biotechnology Center | CSIC in Spain. According to Scopus indexing information, the profile includes 291 documents, 10,146 citations, and an h-index of 47, reflecting a sustained research presence within the scientific literature.[1]

Research Contributions

The research contributions associated with vaccine science include investigations into vaccine platforms, immune responses, and biotechnology-based approaches. Such research supports the broader scientific objective of improving preventive healthcare strategies and strengthening preparedness against infectious diseases.[3]

Publications

The publication record of Carmen Elena Gómez includes peer-reviewed scientific outputs indexed within international research databases. These publications contribute to the understanding of vaccine technologies, molecular biology, and biomedical applications. Selected publications may include DOI-based identification for reliable scholarly access.[4]

Research Impact

Research impact is reflected through citation metrics, publication activity, and contributions to scientific knowledge. The citation count and h-index provide quantitative indicators of academic influence while recognizing that research quality is assessed through broader scholarly evaluation methods.[1]

Award Suitability

The Innovative Research Award acknowledges researchers demonstrating meaningful scientific contributions and advancement of knowledge. Carmen Elena Gómez’s documented research activity in vaccine science, supported by academic publications and measurable research indicators, aligns with the objectives of this recognition category. [2]

Conclusion

Carmen Elena Gómez represents a scientific profile associated with vaccine research and biotechnology innovation. Her academic record, publication activity, and research impact demonstrate continued engagement with internationally recognized biomedical research efforts.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Carmen Elena Gómez, Author ID 35796367700. Scopus.https://www.scopus.com/authid/detail.uri?authorId=35796367700
  2. Global Diseases Research Awards. (2026). Innovative Research Award.
    https://globaldiseases.org/
  3. Delaloye, J., Roger, T., Steiner-Tardivel, Q.-G., Le Roy, D., Knaup Reymond, M., Akira, S., Petrilli, V., Gomez, C. E., Perdiguero, B., Tschopp, J., Pantaleo, G., Esteban, M., & Calandra, T. (2009). Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathogens, 5(6), e1000480.
    https://doi.org/10.1371/journal.ppat.1000480
  4. Gómez, C. E., Perdiguero, B., & Esteban, M. (2021). Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19. Vaccines, 9(3), 243.
    https://doi.org/10.3390/vaccines9030243
  5. Gili, V. F., Carletti, L., Locatelli, A., Rocco, D., Finazzi, M., Ghirardini, L., Favero, I., Gomez, C., Lemaître, A., Celebrano, M., De Angelis, C., & Leo, G. (2016). Monolithic AlGaAs second-harmonic nanoantennas. Optics Express, 24(14), 15965–15975.
    https://doi.org/10.1364/OE.24.015965

Qingju Zhang | Vaccines | Best Researcher Award

Prof. Qingju Zhang | Vaccines | Best Researcher Award 

Researcher | Jiangxi Normal University | China

Prof. Qingju Zhang is a distinguished researcher at Jiangxi Normal University, China, recognized for her significant contributions to synthetic carbohydrate chemistry, glycoscience, and vaccine-related glycoconjugate development. With a portfolio of 44 peer-reviewed publications and over 870 citations across 632 citing documents, she has established a strong scholarly footprint marked by methodological innovation, collaborative strength, and impactful research outputs. Her work focuses on the chemical synthesis, structural modification, and functional exploration of complex oligosaccharides, especially those relevant to pathogenic bacteria such as Acinetobacter baumannii and Bordetella hinzii. Recent publications highlight her leadership in advancing direct glycosylation methods, visible-light-mediated stereoselective transformations, and halogen/hydrogen-bond-assisted activation strategies, reflecting her expertise in contemporary reaction design and mechanistic insight. Her research on carbohydrate-based vaccines exemplifies a translational vision aimed at developing effective immunogens targeting antibiotic-resistant bacterial pathogens. With an h-index of 16 and a network of over 110 international and interdisciplinary co-authors, she collaborates widely across chemistry, microbiology, and biomedical science communities, underscoring her role as a key contributor to global glycoscience research. In addition to pioneering synthetic methodologies, her work advances fundamental understanding of bacterial O-antigen structures and supports the design of next-generation vaccine candidates with potential societal benefits in infectious disease control. Through consistent scholarly productivity, rigorous experimental approaches, and high-impact publications in leading journals such as ACS Catalysis, Organic Letters, and JACS Au, Prof. Zhang continues to enrich the field of carbohydrate chemistry while fostering scientific collaborations that bridge basic research and biomedical application.

Profiles: Scopus | ORCID

Featured Publications

1. Wang, L., Chen, M., Zou, J., Wu, S., Guo, K., Liu, D., Liu, C., Wang, Z., Hansen, T., & Zhang, Q. (2025, August 15). Direct glycosylation of N,N-dimethyl amino sugars via halogen/hydrogen-bonding interactions. ACS Catalysis, 15, 14115–14126. 
Cited by: 1

2. Wang, L., Li, X., Duan, L., Liu, D., Qi, J., & Zhang, Q. (2025, June). Fragments synthesis of Acinetobacter baumannii ATCC 17961 O-Antigen. Synlett.

3. Zhang, Y., Liu, C., & Zhang, Q. (2025, May 23). Recent advances of carbohydrate-based vaccines against Acinetobacter baumannii. European Journal of Organic Chemistry.

4. Zhang, L., Zheng, Z., Zhang, Y., Wu, X., Tu, Y., Liu, C., Wang, Z., Wang, L., Yang, Y., & Zhang, Q. (2025, April 28). Chemical synthesis and antigenic evaluation of oligosaccharides of Bordetella hinzii O-Antigen containing unique amidated 2,3-diacetamido-2,3-dideoxy-alduronic acids. JACS Au, 5, 1903–1913. 
Cited by: 4

5. Wang, Z., Poveda, A., Zhang, Q., Unione, L., Overkleeft, H. S., van der Marel, G. A., & Codée, J. D. C. (2023, June 28). Total synthesis and structural studies of zwitterionic Bacteroides fragilis polysaccharide A1 fragments. Journal of the American Chemical Society. 
Cited by: 15